Navigation Links
Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise
Date:5/18/2009

he, dizziness, tachycardia, hypertension, hypotension, dyspnea, tachypnea, cough, vomiting, diarrhea, constipation, abdominal pain, nausea, hyperhidrosis, myalgia, arthralgia, back pain, pain in extremity, fever, chills, fatigue, hypothermia, pain, malaise, asthenia, and chest pain.

A pharmacovigilance plan for MEPACT, as for all medicinal products, will be implemented as part of the marketing authorization.

Detailed recommendations for the use of MEPACT are described in the Summary of Product Characteristics (SPC) which is published in the European Public Assessment Report (EPAR) and is available in all official European Union languages.

About IDM Pharma

IDM Pharma is focused on the development of innovative cancer products that either destroy cancer cells by activating the immune system or prevent tumor recurrence by triggering a specific adaptive immune response. IDM Pharma is dedicated to maximizing the full therapeutic and commercial potential of its innovative products to address the needs of patients and the physicians who treat these patients. For more information about the company and its products, visit www.idm-pharma.com.

About Takeda Pharmaceutical Company Limited

Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products. Additional information about Takeda is available through its corporate website, www.takeda.com.

Transaction Information

This transaction is structured as an all cash tender offer for all of the outstanding s
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited; IDM Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Takeda to Create Global Centers of Excellence
2. Takeda Receives New Information on Alogliptin (SYR-322) NDA
3. Healthcare Businesswomens Association Announces 2009 Woman of the Year, Dr. Deborah Dunsire, President and CEO of Millennium: The Takeda Oncology Company
4. Welvista Announces Partnering with Takeda to Provide Medication at No Cost to the Uninsured
5. Review of Takedas Febuxostat New Drug Application Continues Past PDUFA Date
6. FDA Adds Three Months to Review of Takedas New Drug Application for TAK-390MR
7. Takedas investigational PPI TAK-390MR demonstrated higher healing rates compared to lansoprazole
8. Takeda Completes Acquisition of Millennium
9. Takeda Commences Cash Tender Offer for all Outstanding Shares of Millennium
10. Takeda, Abbott Announce Plans to Conclude TAP Joint Venture
11. Takeda Announces New U.S. Leadership

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)... keep eating under control, expert says , ...y season means you,ll be faced with a seemingly en... simply give in and eat too much, others deny them... to navigate between overindulgence and deprivatio...n Consult Services at Brigham and Women,s Hospital...
(Date:11/22/2009)... The holiday season is filled with get-togethers...oyous. It can also be stressful and tiring at time...fatigue, and high fat foods -- factors that can, o... the National Foundation for Cancer Research has d...ensure a happier, more healthful holiday season, a...
(Date:11/22/2009)...ov. 21 Congressman Chak...n the United States Senate,s vote tonight to proce...: ,, "Senators Arlen Specter and Bob Casey dese...nians for casting stand-up, critical votes in the ...c Affordable Health Care Reform legislation to ful...
(Date:11/21/2009)... Nov. 21 DNC Chairman T...Senate voted to begin full debate of health insura...newscom.com/cgi-bin/prnh/20080519/DNCLOGO ) ,... the road to enacting health insurance reform. By ...ll now have an opportunity to debate the health re...
(Date:11/21/2009)...ov. 21 Milvia Lopez, by her attorn...ntly filed suit, in Supreme Court, New York County...es that while Ms. Lopez underwent a routine transe... HOSPITAL , doctors used an HIV infected scope exp...at several hours after being discharged from the p...
Breaking Medicine News(10 mins):Health News:Go Healthy, Not Hungry for Holiday Eating 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 3Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2
...ks of the,holidays are upon us, everyone wants to ...r, veteran stylist and owner of The Fisher Experie... there are several things you,should remember when...d friends at home, everyone wants to look,their be...
...ren,s Center scientists has figured out why a resp...oculate children against the infection instead cau...pped efforts to make a better one. The findings, p... researchers say. The new findings also debunk a p...
...tement , , VIRGINIA BEACH, Va., Dec. 15, 2008...today that it filed a universal shelf registration...hange Commission on December 15, 2008. The registr...nd on terms to be determined at the time of the ap...
...Food,and Drug Administration (FDA) approved Abbott...capsules for use along with diet to help lower tri...holesterol in patients with lipid,problems. TRILI...ation of a fibrate with a statin to further improv...
...plications, experts say , , MONDAY, Dec. 1...ealth insurance are more like to fare poorly after...ntestinal condition known as diverticulitis, a new...earchers say. , "Uninsured patients are more likel...
...h School Student Volunteers Collaborate in Musical... N.J., Dec. 15 Sharing The Arts, a Hawthorne, ...nd conservatory bringing together individuals with...needs are performing in its production of "Charli...
Other Medicine News:Health News:Just in Time for the Holiday Rush, Braintree Stylist Bruce Fisher Offers Holiday Style & Beauty Tips 2Health News:Hopkins-led team solves failed vaccine mystery 2Health News:AMERIGROUP Files Shelf Registration Statement 2Health News:Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 2Health News:Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 3Health News:Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 4Health News:Uninsured Face Worse Outcomes After Diverticulitis 2Health News:Uninsured Face Worse Outcomes After Diverticulitis 3Health News:Sharing The Arts & Ridgewood High School Present Musical Production of Charlie and The Chocolate Factory 2
(Date:11/19/2009)...ARK, Ill., Nov. 19 The ... as one of its Most Admired Corporate Dealmakers f...d Abbott as its Most Admired Dealmaker in pharma/b...uisitions and divestitures since January 2006. ,...usiness portfolio with a focus on high-growth, inn...
(Date:11/19/2009)...of International Internet Week of Action ,, SI...-- The U.S. Food and Drug Administration today com...rt, called the International Internet Week of Acti...ing medical products. ,, (Logo: http://www.new...ing the effort, the FDA,s Office of Criminal Inves...
(Date:11/19/2009)...ON, N.J., Nov. 19 Impliant, Inc., ...o traditional spinal fusion surgery, announced tod...anagement team as the Vice President of Clinical a...w.newscom.com/cgi-bin/prnh/20080527/NETU060LOGO ...regulatory experience in the spinal and medical de...
Breaking Medicine Technology:The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team 2Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team 3Mobile MedCheck Brings Back House Calls 54959 1Mobile MedCheck Brings Back House Calls 54959 2Mobile MedCheck Brings Back House Calls 54959 3Mobile MedCheck Brings Back House Calls 54959 4Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 1Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 2Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 3Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 4Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 5Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 1Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 2Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 3
...ree Oritavancin Studies Presented at ECCMID/ICC, M...ganta,Therapeutics today announced results from tw...cin to stop bacterial growth in vitro,when tested ...ne,study demonstrating the activity of oritavancin...ia. Oritavancin, a novel,lipoglycopeptide antibiot...
...istorical Analyses Help Plan for Future Pandemics ...tent riddles of the,deadly 1918 Spanish influenza ...rying severity. Why were some municipalities such ...s like Philadelphia,when both implemented similar ...according to two independent studies funded by the...
Other Medicine Technology:Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 2Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 3Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 4Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 5Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 6Rapid Response was Crucial to Containing the 1918 Flu Pandemic 2Rapid Response was Crucial to Containing the 1918 Flu Pandemic 3Rapid Response was Crucial to Containing the 1918 Flu Pandemic 4Rapid Response was Crucial to Containing the 1918 Flu Pandemic 5
Straight Iris Scissors (Ring Handle)
Surpass Superfusion
...es its hallmark 50 and 100 ms scans to perform tru...scan protocols and proprietary cardiac analysis so...targets and two x-ray detector rings to image the ...ial perfusion and wall motion. The EBT C300 also s...
Corneal Scissors (Westcott Straight Tenotomy Scissors)
Medicine Products: